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Abstract
Some evidence suggests that retinal pigment epithelium (RPE) can express nicotinic acetylcholine receptors (nAChRs) as
described for other epithelial cells, where nAChRs have been involved in processes such as cell development, cell death,
cell migration, and angiogenesis. This study is designed to determine the expression and activity of a7 nAChRs in RPE
cells. Reverse transcriptase (RT)-PCR was performed to test the expression of nicotinic a7 subunit in bovine RPE cells.
Protein expression was determined byWestern blot and by immunocytochemistry. Expression of nicotinic a7 subunits was
also analyzed in cryostat sections of albino rat retina. Changes in protein expression were tested under hypoxic conditions.
Functional nAChRs were studied by examining the Ca2+ transients elicited by nicotine and acetylcholine stimulation in
fura-2–loaded cells. Expression of endogenous modulators of nAChRs was analyzed by RT-PCR and Western blot in
retina and RPE. Cultured bovine RPE cells expressed nicotinic receptors containing a7 subunit. RT-PCR ampliﬁed the
expected speciﬁc a7 fragment. Western blotting showed expression at the protein level, with a speciﬁc band being found at
57 kDa in both cultured and freshly isolated RPE cells. Expression of nAChRs was conﬁrmed for cultured cells by
immunoﬂuorescence. Immunohistochemistry conﬁrmed a7 receptor expression in rat RPE retina. a7 receptor expression
was down-regulated by long-term hypoxia. A small subpopulation of RPE cultured cells showed functional nAChRs, as
evidenced by the selective response elicited by nicotine and acetylcholine stimulation. Expression of the endogenous
nicotinic receptors’ modulator lynx1 was conﬁrmed in bovine retina and RPE, and expression of lynx1 and other
endogenous nicotinic receptor modulators (SLURP1 and RGD1308195) were also conﬁrmed in rat retina. These results
suggest that nAChRs could have a signiﬁcant role in RPE, which may not be related to the traditional role in nerve
transmission but could more likely be related to the nonneuronal cholinergic system in the eye.
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Introduction
Nicotinic acetylcholine receptors (nAChRs) are neurotransmitter-
gated ion channels that are widely distributed throughout the ner-
vous system, where they have been attributed an important role in
processes such as learning and memory. Their deﬁcit has been
related to diseases, such as Alzheimer’s and Parkinson’s as well as
to schizophrenia (Lindstrom, 1997; Newhouse et al., 1997). nAChRs
are formed by the homomeric or heteromeric combination of ﬁve
protein subunits. At least 12 different subunits have been described in
the mammalian nervous system (a2–a10 and b2–b4), which can
coassemble to form functional pentamers with different properties
depending on their composition (Millar, 2003; Gotti & Clementi,
2004).
It is now fully recognized that nAChRs also play important
roles in nonexcitable cells. Nonneuronal cholinergic systems are
expressed in different cells and tissues and are involved in the
regulation of their functions. Moreover, it has been shown that
cholinergic dysfunction is related to the pathophysiology of
diseases even though a systematic analysis of all the components
of the nonneuronal cholinergic system in different diseases has not
yet been performed (Kawashima & Fujii, 2008; Wessler &
Kirkpatrick, 2008). Thus, expression of nAChRs has been reported
in several types of cells, including the epithelial cells of bronchial
epithelium (Maus et al., 1998; Wang et al., 2001), keratinocytes
(Zia et al., 2000), nasal epithelium (Blank et al., 1997), vascular
endothelial cells (Macklin et al., 1998; Wang et al., 2001), or
lymphocytes and peripheral blood cells (Toyabe et al., 1997; Sato
et al., 1999; Benhammou et al., 2000). The nAChRs have also been
involved in different cell processes (reviewed by Wessler &
Kirkpatrick, 2008). In keratinocytes, a7 nicotinic receptors have
been proposed as mediators in maturation, differentiation, migration,
and apoptosis (Zia et al., 2000; Nguyen et al., 2001; Chernyavsky
et al., 2004). It has also been stated that a3 and a7 receptors control the
migratory function of these cells through different effector proteins
(kinases and GTPases).
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Nicotinic receptors are modulated by different conditions and
agents. In this sense, hypoxia appears to modulate a7 nAChRs in
cholinergic and noncholinergic systems, both increasing and de-
creasing expression of nicotinic receptors, depending on the con-
ditions tested. For instance, Heeschen et al. (2002) showed that a
hypoxic stimulus of 4 h increases expression of a7 nAChRs in human
umbilical vein endothelial cells. Otherwise, it has been reported that
long-term hypoxia decreases the expression of nicotinic a7 receptors
in the adrenomedullar gland (Ducsay et al., 2007).
In vivo nonneuronal activity of nAChRs is also modulated by
somemembers of the Ly-6/neurotoxin gene family, such as SLURP-
1, SLURP-2, or lynx1, among others (Miwa et al., 1999; Grando,
2008; Kawashima & Fujii, 2008). Lynx1, homologous to a-bungar-
otoxin, colocalizes with a7 and b2 nicotinic subunits and acts as an
allosteric modulator of nAChRs in vivo, balancing neuronal activity.
It has been proposed that lynx1maintains both a lowACh sensitivity
and a safety margin against agonist overstimulation of nAChRs
(Miwa et al., 2006). Expression of these endogenous modulators of
nAChRs such as lynx1, SLURP-1, or SLURP-2 has not yet been
described in the retina, although some works have reported the
expression of SLURP1 in whole eye preparation (Mastrangeli et al.,
2003) or tears (Favre et al., 2007).
There is some evidence suggesting that the retinal pigment
epithelium (RPE) can express nAChRs. RPE is an epithelial
monolayer of highly specialized nonexcitable cells, which is
located between the neural retina and the vascular choroid. This
layer plays a key role in the mechanical and metabolic support of
photoreceptors. Moreover, evidence suggests that RPE is also
involved in functions, such as eye growth control (Stone et al.,
2001). This process may involve cholinergic mechanisms that act
throughmuscarinic receptors. In this sense, a number of studies have
shown that the muscarinic antagonist atropine delays the develop-
ment of myopia in several animal models (Raviola & Wiesel, 1985;
Stone et al., 1991; Tigges et al., 1999). Stone et al. (2001) suggest
a role for nAChRs on RPE function. They reported that chlorisond-
amine, which is a substance that accumulates in neurons with
nicotinic receptors, induces RPE layer degeneration, while other
classical nicotinic antagonists cause no damage to the epithelial
layer. This fact led the authors to suggest the possibility that RPE
could also express nAChRs.
The aim of this work was to characterize the presence and
functionality of a7 nAChRs in RPE and test their modulation by
stimulus such as hypoxia as well as to explore the expression of
endogenous modulators of nAChRs in the retina that could inﬂuence
activity of nAChRs in RPE.
Materials and methods
Cell culture
RPE from cow eyes obtained from the municipal slaughterhouse in
Orihuela (Spain) was isolated using standard techniques for
cellular dissociation and isolation. Brieﬂy, after the retinas were
removed, the eyecups were incubated with 0.5% trypsin–EDTA for
45 min. Dissociated cells were concentrated by centrifugation and
resuspended in dulbecco’s modiﬁed eagle medium containing
antibiotics (50 lg/ml gentamicin and 2.5 lg/ml amphotericin B)
and bovine fetal serum (FCS, 10%). The cells were grown on plastic
ﬂasks at 37°C in 5% CO2. The culture medium was changed every
2 days. Primary cultures aged between 4 and 6 weeks were
subcultured following treatment with trypsin/EDTA. In order to
avoid opacities caused by the melanin granules present on the RPE
explants and ﬁrst passages, unless otherwise indicated, cells cultures
were used after four passages, where pigmented granules were not
present. The conﬂuent cultures appeared to be monolayered, with
RPE cells showing a ﬂattened appearance.
Reverse transcriptase–PCR protocol
Total RNA was extracted using the GenElute Mammalian Total
RNA Miniprep Kit (Sigma, St. Louis, MO), according to the
manufacturer’s instructions. Contaminating DNA was removed
using DNAse I (1 U/lg total RNA; Fermentas, Glen Burnie, MD).
Reverse transcription was performed with 1 lg RNA in the presence
of 1.25 lM random nonamers (Sigma), 1 mM dNTPs (Fermentas),
20 U of ribonuclease inhibitor (Fermentas), 50 mM Tris-HCl (pH
8.3), 50 mMKCl, 4 mMMgCl2, 10 mM dithiothreitol, and 200 U of
reverse transcriptase (RT, RevertAid M-MuLV Reverse Transcrip-
tase; Fermentas) at 42°C for 60 min. Negative controls without RT
were added. For the PCR reaction, we used speciﬁc primers for a7
nicotinic receptor subunits, based on Criado et al. (1997). As control
ampliﬁcations, we used the glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) primers described by Yuan et al. (2003). The
following CRALBP- and RPE65-speciﬁc oligonucleotides were
used for RPE characterization: CRALBP forward: GAAGAGGAA-
CAGGAGCTCCG, CRALBP reverse: CTTTGAACCGAGCTGG-
GAAGG, RPE65 forward (described by Vogel et al., 2007):
TGGAGATTAACATCCCCGTCACC, and RPE65 reverse: TAT-
CAGCTGTAGAGGACTTTGGCT.
To analyze endogenous modulator expression, the primers used
were the following: lynx1 bovine forward: CCACATCCCTGCTC-
TCACTC, reverse: GTGGCCAGGAGTATAAGGGC; SLURP1
rat forward: CCACGGCCATTAACTCATGC, reverse: CACGG-
AAGCAACAGAAGACAG; RGD1308195 rat forward (based on
Moriwaki et al., 2007): ATGAGGCTTCCCTTCTGGTTC, reverse
(based on Moriwaki et al., 2007): TCAGTCCCTGTTGCAGAG-
ATT; and lynx1 rat forward: CATGACCCACTTGCTGACAG,
reverse: GGATGAAGGTGAGGAAGTCC.
Complementary DNA (cDNA) was PCR ampliﬁed under
standardized conditions as follows: denaturation at 94°C for 2
min, followed by 35 cycles of 30 s each at 94°C, 1 min at 57°C
(CRALBP and RPE65) or 55°C (a7) or 30 s at 59.5°C (bovine
lynx1, rat SLURP1, and RGD1308195) or 58°C (rat lynx1), 1 min at
72°C, and a ﬁnal elongation step at 72°C for 15 min. Negative
control without cDNA was present in all ampliﬁcations. PCR
products were separated by electrophoresis in 1.5% agarose gels.
Identity of the ampliﬁed sequences was conﬁrmed by RT-PCR.
Western blotting
Western blot was performed using standard techniques. After
washing with sodium phosphate-buffered saline (PBS), the dis-
sociated cells were lysed in the presence of a protease inhibitor
cocktail from Sigma. Protein concentrations were determined by the
Bradford method, using the Bio-Rad Protein Assay Dye Reagent
(Bio-Rad, Herculez, CA). Denatured proteins were run on 10%
sodium dodecyl sulfate-polyacrylamide gels. Proteins were blotted
onto polyvinylidene diﬂuoride membranes. Bands were identiﬁed
using Lumi-light Western Blotting Substrate (Roche Applied Sci-
ence, Indianapolis, IN) according to the manufacturer’s instructions.
Molecular weight standard markers were used (Pageruler Unstained
Protein Ladder and Prestained Protein Molecular Weight Marker;
Fermentas). For a7 nicotinic subunit, primary antibody anti-a7
monoclonal antibody mAb319 (Sigma) was used at 2.5 lg/ml.
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Secondary antibody: 40 ng/ml goat anti-rat IgG conjugated with
horseradish peroxidase (HRP) (Jackson Immunoresearch Laborato-
ries, West Grove, PA). For lynx-1 detection, primary antibody T-15
(Santa Cruz Inc, Santa Cruz, CA) was used at 2 lg/ml. Secondary
antibody: donkey anti-goat IgG–HRP conjugated (Santa Cruz Inc)
at 0.2 lg/ml. The anti-b-actinmonoclonal antibody (cloneAC-15)was
used as loading control.
Immunocytochemistry for cultured cells
Using standard techniques, RPE cells were grown on glass cover-
slips until conﬂuence, washed with PBS, and ﬁxed for 20 min with
4% paraformaldehyde in PBS at 4°C. Cells were permeabilized
with 0.2% Triton X-100 in PBS for 20min. Nonspeciﬁc binding was
blocked by incubating with 1% BSA in PBS for 45 min at room
temperature. Cells were incubated with primary antibody in PBS
plus 1% bovine serum albumin (BSA) overnight at 4°C in a wet
chamber. Secondary antibody was applied in PBS for 1 h at room
temperature. Cells were observed with Leica confocal microscopy
(Leica TCS SP2; LeicaMicrosystems,Wetzlar, Germany). Negative
controls lacking primary and secondary antibodies were added. The
thin morphology of the cultured monolayers limited the use of
confocal Z-sections and discriminations about cell polarization and
labeling distribution.
Immunohistochemistry for tissue sections
Three Sprague Dawley were anesthetized with a lethal dose of
ketamine (0.5 g/kg i.p.) and eyes were enucleated. The eyecups were
ﬁxed in 4% paraformaldehyde in 0.1 m PBS at pH 7.4 for 2 h and then
washed in 0.1 m PBS before being cryoprotected in 10% sucrose for
0.5 h, 20% sucrose for 1 h, and 30% sucrose overnight at 4°C. The
next day, they were embedded in optimal cutting temperature
compound and cut into 14-lm thick radial sections on a cryostat
and mounted on glass slides. Sections were incubated in 10% normal
donkey serum (Jackson Immunoresearch Laboratories) to avoid non-
speciﬁc staining. Without washing, they were then immunostained for
rat anti-a7 nicotinic receptor subunit antibody diluted in PBS
containing 0.5% Triton X-100. Sections were incubated overnight at
room temperature. The next day, sections were washed in 0.1 m PBS.
To visualize antibody binding patterns, they were transferred to
donkey anti-rat IgG coupled to ﬂuorescein isothiocyanate (FITC) in
0.1 m PBS 0.5% Triton X-100 for 1 h. Finally, the sections were
washed in 0.1 m PBS, mounted in watermount (Vector Laboratories,
Burlingame, CA), and coverslipped for viewing by confocal micros-
copy. To control for nonspeciﬁc staining, some sections were stained
omitting the primary antibody.
Primary antibodies: 5 lg/ml mAb319 (Sigma) for a7 nicotinic
subunit. For RPE characterization, 4 lg/ml of goat polyclonal anti-
CRALBP (L-19) antibody were used (Santa Cruz Inc). Secondary
antibodies: Goat anti-rat Alexa 546 (10 lg/ml; Molecular Probes,
Eugene, OR), donkey anti-rat Alexa 488 (10 lg/ml; Molecular
Probes), and donkey anti-goat 4 lg/ml (Santa Cruz Inc). Negative
controls without primary or/and secondary antibodies were included.
Fluorescence measurements
Fluorescence determinations were made using a conventional
ﬂuorescence microscopy system. Prior to the recordings, cells
were incubated (37°C) with the ﬂuorescent Ca2+ indicator fura-2
acetoxy methyl ester (fura-2 AM, 4 lM; Molecular Probes) for 45
min in culture medium. After extensive washing with external
solution, the cells were tested with brief applications of 200 lM
nicotine or 200 lM acetylcholine plus 0.5 lM atropine sulfate to
block muscarinic responses. In order to prevent nAChR desensiti-
zation, successive nicotine and acethylcholine applications were
separated by at least 60-s intervals. In some experiments, the
external medium was supplemented with 10 mM Ca2+ (12 mM
ﬁnal concentration) in order to amplify the ﬂuorescence response.
The level of intracellular free Ca2+ concentration was taken as the
ratio between the digital images obtained with 340 and 380-nm
excitation wavelengths. Emission was monitored at 510 nm. During
recordings, cells were continuously superfused using a gravity-
driven perfusion system with separate tubes for normal and drug-
containing external solutions. The tube ends were positioned
50–100 lm away from the cells and connected on the other side to
a fast exchanger system (RSC-200; Biologic, Claix, France).
Hypoxia induction
Flasks containing approximately 7 3 106 bovine RPE and glass
coverslips containing RPE conﬂuent cultures were incubated
without FCS in a sealed incubator at 3% O2 for 72 h. Control cells
were maintained in normoxic conditions. After the stimulus, ﬂask
cells were collected and total proteins were immunoblotted. Cells in
coverslips were ﬁxed and used for immunoﬂuorescence. Both were
probed against mAB319 antibody for a7 nAChR.
Solutions and chemicals
The external solution had the following composition (in millimolar):
NaCl, 140; KCl, 5.6; MgCl2, 2; CaCl2, 2; Glucose, 10; and HEPES–
NaOH, 10; pH 7.4. Culture media were purchased from GIBCO
(Grand Island, NY). Unless otherwise indicated, all the other
chemicals used came from Sigma.
Results
RPE characterization
Using speciﬁc oligonucleotides for the speciﬁc RPE markers
CRALBP and RPE65, messenger RNA (mRNA) expression was
shown by RT-PCR from RPE cultured cell RNA. Sequence was
conﬁrmed by DNA sequencing. Moreover, 100% of cultured
monolayers were stained with a goat polyclonal anti-CRALBP
antibody (Fig. 1A–1C).
a7 nAChRs mRNA expression
In order to test for the presence of nAChRs in RPE, the expression
of a7 nicotinic receptor subunits was analyzed by RT-PCR in RPE
cultured cells. As shown in Fig. 1D, the oligonucleotide primers for
nicotinic a7 subunit (see Materials and methods) ampliﬁed a 280 bp
fragment. This same fragment was also ampliﬁed when RNA from
total retina was used (positive control). Negative controls did not
amplify any fragment. The GAPDH primers described by Yuan
et al. (2003) (see Materials and methods) ampliﬁed a 238 bp band
corresponding to an mRNA template. No 458 bp band from
contaminating DNA was observed (not shown).
Protein expression
To determine whether transcripts encoding the a7 nicotinic sub-
units detected in RPE by RT-PCR were translated, Western blotting
was performed with cultured RPE cells. Total retina protein extract
was used as positive control. Nicotinic a7 subunit expression was
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also tested in freshly isolated RPE cells. Samples were probed with
anti-a7 monoclonal antibody mAb319. As shown in Fig. 1E,
mAb319 detected a ~57 kDa band corresponding, which was also
present in all three protein extracts.
Immunoﬂuorescence staining using antibodies against a7 sub-
unit was performed in cultured RPE cells to conﬁrm the expression
of nAChRs on these cells. As can be seen in Fig. 1F, ﬂuorescence
activity was observed under the microscope in RPE cells labeled
with mAb319, indicating the expression of a7 nicotinic subunits.
Fluorescence was mostly distributed around the cell nucleus. No
evident labeling was observed when no primary antibody was added
(Fig. 1G), or when the secondary antibody was absent (not shown).
Effect of hypoxia on expression of a7 nAChRs
In order to study the possible modulator effect of hypoxia on
expression of a7 nAChRs in RPE cells, we applied a long-term
hypoxia stimulus of 72 h to the RPE cell culture. After this time,
protein extracts were probed with mAb319 antibody. As Fig. 2
shows, a7 expression decreased signiﬁcantly after long-term hyp-
oxia compared with normal conditions.
Functional nAChRs detection
In order to test for the presence of functional nAChRs in RPE in
culture, we examined the Ca2+ transients elicited by both nicotine
and acetylcholine (200 lM) in fura-2–loaded cells. As shown in
Fig. 3A and 3B, a small subset of fura-2–loaded RPE cells displayed
an apparent elevation of intracellular free calcium concentration
when stimulated with nicotine pulses (four responsive cells from
a total of 70 optic ﬁelds viewed, representing 0.18% of total cells).
Similar Ca2+ transients were observed when 200 lM acetylcholine
was applied (29 responsive cells in 50 microscopic ﬁelds, representing
Fig. 1. Bovine RPE cells characterization and expression of a7 nAChRs. (A) Representative 103 image of a four-passages culture. Cells
were cultured for up to 7 days till they were grown to conﬂuence. (B) Representative RPE cell culture stained with a goat polyclonal
antibody against the RPE-speciﬁc marker CRALBP. (C) RT-PCR ampliﬁcation with speciﬁc primers for CRALBP (C) and RPE-65 (R). (D)
RT-PCR ampliﬁcation from bovine RPE mRNA. 1 lg of total RNA puriﬁed from cultured RPE (E) and whole retina (R) was reverse
transcribed and ampliﬁed with speciﬁc oligonucleotides for a7 nicotinic subunit. Negative PCR control without cDNA (C) and RNA
standards (St) are also shown. A total volume of 12.5 ll was loaded in each lane, onto ethidium bromide–stained 1.5% agarose gel. (E)
Western blot from freshly isolated RPE (F), total retina (R), and cultured RPE (E) total proteins expected immunoreactive bands for anti-a7 is
observed at 57 kDa. Monoclonal antibody mAb319 HRP conjugated was used. Each lane contained 20 lg of total protein. (F)
Immunocytochemistry confocal images of representative RPE cells in culture labeled with mAb319 antibody (against a7 nAChRs). Note the
immunoreactive prolongations of cultured cells marked by arrows. (G) Representative negative control image without primary antibody.
Fig. 2. Hypoxia modulation of expression of a7 nAChRs. (A) Western blot
showing total proteins extract from RPE cells maintained in hypoxia for 72 h
(H) or in control normoxic conditions (N), probed with mAb319 antibody.
Bands for b-actin expression are shown as control. (B) Histogram showing
expression of a7 nAChRs normalized to b-actin under control (normoxia)
and hypoxia conditions. The values represent the means 6 s.d. from
triplicates.
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2% of the cells, Fig. 3C). However, only a subset of acetylcholine-
sensitive RPE cells (approximately 10%) responded to 200 lM
acetylcholine when coapplied with 0.5 lMatropine sulfate, a selective
inhibitor of muscarinic acetylcholine receptors, resulting in a respon-
siveness of 0.21% (Fig. 3D).
Tissue sections
To further assess expression of a7 nAChRs in RPE, sections of
albino rat retina were immunostained with antibodies against a7
nAChRs. Fig. 4A shows pigment epithelial cells immunoreactivity
for a7 antibodies. An increase of immunoreactivity was found in the
apical surface of these cells. No immunostaining was found in
control sections (Fig. 4B, 4D, and 4F). In the retinal sections where
the photoreceptors’ outer segment was not detached, the immunos-
tained apical processes of the pigment epithelium were identiﬁed,
located between outer segments of the photoreceptors (Fig. 4C and
4E, arrows).
Expression of endogenous modulators of nAChRs
In order to test the expression of endogenous modulators of
nAChRs in the retina and RPE, we tested the expression of lynx1
(a member of Ly-6/neurotoxin gene family) reported as a7 modu-
lator. By using total mRNA from bovine retina and RPE and with
speciﬁc primers, RT-PCR ampliﬁed a band of 371 pb corresponding
to the lynx1 gene in both bovine retina and freshly isolated RPE
(Fig. 5A). By Western blot, we detected a single band of 17 kDa,
which was higher than the expected 9-kDa band. The same fragment
size was obtained for the rat brain sample used as positive control.
Although further investigation is needed to clarify this aspect, it
could be due to protein phosphorylation (Fig. 5B). The same
positive results for RT-PCR ampliﬁcation andWestern blot analysis
were obtained for rat retina (not shown). We also obtained positive
RT-PCR ampliﬁcation for lynx1, RGD1308195, and SLURP-1
expression in rat retina (Fig. 5C).
Discussion
The present work provides evidence that a7 nAChRs are present in
RPE cells. Stone et al. (2001) had already reported that chlorisond-
amine, which is a substance that accumulates in neurons with
nicotinic receptors, induced RPE layer degeneration, thus suggest-
ing the possibility of expression of nAChRs in RPE cells. However,
to our knowledge, this is the ﬁrst direct evidence that nAChRs are
expressed in RPE. These nicotinic receptors can be part of the
nonneuronal cholinergic system in the eye.
The nAChRs are widely expressed in the eye. The retina is one
of the tissues that expresses the greatest variety of nAChRs. Nico-
tinic receptors have a speciﬁc distribution among retinal layers, and
their expression is regulated during development and by visual
experience (Vailati et al., 2003; Moretti et al., 2004; Marritt et al.,
2005). Acting through nAChRs, acetylcholine seems to play an
important role in retinal and central visual pathways. It is possible
that the increased expression of certain receptor subtypes is de-
pendent on activity and only appears after the ﬁrst use of the visual
system (Stone et al., 2001; Vailati et al., 2003; Moretti et al., 2004;
Marritt et al., 2005). It has also been demonstrated that visual dep-
rivation triggers changes in expression of nAChRs (Moretti et al.,
2004).
Understanding of the nonneuronal cholinergic system is just
beginning to emerge. ACh is present in the vast majority of human
Fig. 3. Nicotine- and acetylcholine-evoked responses in cultured RPE cells. (A) Typical RPE cells in culture seen under ﬂuorescence
microscopy. Cells were incubated with the ﬂuorescent Ca2+ indicator fura-2 acetoxy methyl ester for 45 min. Bar 100 lm. (B) Intracellular
Ca2+ transient elicited by nicotine (Nic) application in the cultured cell pointed at in (A) by the arrow. In order to obtain measurable
responses, external medium was supplemented with 10 mM Ca2+ prior, during, and after the nicotine pulse. Horizontal black bars indicate
the time point and duration of drug applications. (C) Intracellular Ca2+ response evoked by acetylcholine (ACh) on another two single RPE
cells. (D) Intracellular Ca2+ response recorded in the same cells than in (C) when acetylcholine was coapplied with atropine sulfate.
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cells, including epithelial, endothelial, or immune cells, and it can
play different roles in cell biology and homeostasis with biological
and clinical signiﬁcance (Grando, 2008; Kawashima & Fujii, 2008;
Wessler & Kirkpatrick, 2008). In the eye, the role of nonneuronal
cholinergic system has not yet been widely studied. However, if we
take into account the relevant roles of this system in most other
tissues, it would not be surprising to ﬁnd similar roles in retina and
RPE layers. In this sense, one could expect the presence of non-
neuronal nAChRs in RPE given that they are expressed in numerous
epithelial cells from different tissues, such as airway surface epi-
thelium, alveolar type 2 cells, skin (e.g., keratinocytes and melano-
cytes), intestine (e.g., surface epithelium or colonic epithelial cell
line), ovary, or urothelium (Wessler & Kirkpatrick, 2008).
In this work, nicotinic subunit a7 transcripts were detected in
bovine RPE by RT-PCR, and protein expression was conﬁrmed by
Western blot and immunocytochemistry. Protein expression was
detected in both freshly isolated and cultured bovine RPE after four
passages. Immunoﬂuorescence was mostly distributed around the
cell nucleus and may be associated with the endoplasmic reticulum,
as described for a7 nAChRs in rat hippocampus by Fabian-Fine
et al. (2001) and on glutamatergic axon terminals in the rat ventral
tegmental area by Jones and Wonnacott (2004).
Immunohistochemistry in sections of rat retina showed ﬂuores-
cence in RPE layer, indicating that nAChRs are expressed in the
RPE layer under normal conditions. As supporting data of RPE
expression of nAChRs, we also detected the expression of a3
nicotinic receptors in RPE, at least at the mRNA level (not shown).
Our data indicate that cultured RPE cells, at least at early
culture passages, seem to be a good model for studying nicotinic
receptor composition and function in RPE. They are also useful in
studying the relationship of nAChRs and the retina and the role in
the visual system. In order to characterize our cell cultures and to
discard other cell type contamination, expression of the RPE-speciﬁc
markers CRALBP and RPE65 was tested and conﬁrmed by RT-
PCR. Moreover, CRALBP expression was detected by immunocy-
tochemistry, with 100% of the cells being positively stained. To our
knowledge, nicotinic receptors have been described in the eye in
bipolar, amacrine, and ganglion cells (Dmitrieva et al., 2007).
Fig. 4. Immunohistochemistry confocal images of expression of a7 nAChRs in rat RPE. (A, C) Vertical section of rat retina showing
pigment epithelium cells labeled with antibodies against a7 nAChRs. (B, D) Control retinas. (E) High magniﬁcation of (C) showing a7
nAChRs immunoreactivity processes of pigment epithelium cells located between photoreceptor outer segments, marked by arrows. (F)
High magniﬁcation of (D). Nuclei stained with TOPRO-3 in blue. Bar 20 lm. CHO, Choroid; OS, Photoreceptor outer segments.
Fig. 5.Retinal expression of nAChRs’ endogenous modulators. (A) RT-PCR
ampliﬁcationwith lynx1 speciﬁc oligonucleotides from bovine retina (R) and
freshly isolated RPE (F). (B) Western blot showing immunoreactive bands
obtained with lynx1 antibody in total bovine retinal extract proteins (R).
Band obtained from rat brain is shown as positive control (C). (C) RT-PCR
ampliﬁcation from rat retinal total RNA using speciﬁc lynx1 (L),
RGD1308195 (RGD), and SLURP-1 (S) oligonucleotides.
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However, any probability of neuronal survival was eliminated after
four culture passages (about 2 months of culture). Under better
conditions, retinal ganglion cells can survive for about 4 weeks
without successive passages (Romano & Hicks, 2007). Furthermore,
while the medium used is suitable for RPE cells, it lacks enrichment
factors to promote neuronal survival. Cell contamination could also
come from nonneuronal cells, such as ﬁbroblasts, but this possibility
has also been discarded, since the presence of these cells would be
evident in the ﬁrst two culture passages, since RPE cells grow slowly
and their melanin granules give them a characteristic morphology (Lu
et al., 2007).
Since evidence exists showing that nAChRs are modulated by
hypoxia, we have carried out studies to determine if RPE nAChRs
are also modulated by oxidative stress. Expression of a7 nAChRs
appeared to be modulated by long-term hypoxia, decreasing its
expression after 72 h of hypoxic stimulus. These data are in
accordance with data of Ducsay et al. (2007). The biological or
clinical relevance of this result should be clariﬁed.
Calcium imaging analysis was used to test for the presence of
functional nAChRs in cultured RPE cells. It is well known that
adequate stimulation of nAChRs induces Ca2+ inﬂux through ion
pores (Fucile et al., 2004), which can be detected by monitoring
intracellular calcium levels (Lax, 2008). The calcium transients
measured will vary depending on both current amplitude and
fractional Ca2+ permeability. In cultured cerebellar granule neurons
(CGN), cells with detectable Ca2+ transients displayed nicotine-
evoked currents more than three times larger than those from rando-
mly recorded cells (Fucile et al., 2004). In our experiments, the
percentage of cells with detectable Ca2+ transients were 0.18% for
200 lM nicotine and 0.21% for 200 lM acethylcholine plus 0.5 lM
atropine. The low number of cells with measurable responses contrast
with the immunostaining in Fig. 1F. This difference could be due to
(a) the low sensibility of the calcium imaging analysis, in part because
of the thinness of RPE cells; (b) cytoplasmic location of nAChRs
and/or; (c) low functionality of nAChRs in RPE cultured cells, for
example, because of endogenous modulation.
These results per se can neither conﬁrm nor reject the role of
nAChRs as traditional neurotransmitter-gated ion channels in RPE.
On one hand, they are very similar to those reported in previous
experiments in which Ca2+ transients were measured in CGN (Fucile
et al., 2004; Lax, 2008); however, on the other hand, the small number
of cells responding to nicotinic agonist stimulus could better ﬁt with
a role in the nonneuronal cholinergic system in the RPE.
Since there is increasing evidence of the relevant role of
nonneuronal nAChRs ligands in nicotinic function and modulation
(Miwa et al., 1999; Grando, 2008; Kawashima & Fujii, 2008), we
tested and conﬁrmed the expression of lynx1, the endogenous
modulator of a7 receptor, in the bovine retina and RPE. We also
showed the expression of other members of the Ly-6/neurotoxin
gene family in rat retina: lynx1, RGD1308195, and SLURP-1.
These data support the idea that nicotinic receptors in RPEmay have
a signiﬁcant role in aspects similar to those observed in other
epithelial cells (Grando, 2008; Kawashima & Fujii, 2008).
We propose that nAChRs in RPE could be involved in cell pro-
tection mechanisms. Available data show that nicotine and some
nicotinic agonists exert a protective role against amyloid beta–
induced toxicity through nAChRs (Kihara et al., 1999; Shimohama&
Kihara, 2001; Martin et al., 2004; de Fiebre & de Fiebre, 2005). In
this regard, it is known that amyloid beta depositions (a major
component of senile plaques found in Alzheimer’s patients) are
present in RPE drusen of patients with age-related macular de-
generation (AMD), and accumulation of this peptide induces RPE
atrophy (Yoshida et al., 2005). AMD is one of the leading causes of
irreversible vision loss and blindness in industrialized countries,
occurring in about 10–25% of people over 65 years of age (Klein
et al., 1992; Zarbin, 1998; Klaver et al., 2001; Chakravarthy et al.,
2010). On the other hand, in PC12 cells, it has been demonstrated
that during early stages of damage by oxidative stress, there is a
reduction in a-bungarotoxin binding sites and expression of nAChRs
selectively decreases (Guan et al., 2001).
In the mechanisms of cell protection involving nAChRs, endo-
genous modulators such as SLURP1, SLURP2, or lynx1 can play
a relevant role. In this sense, it has been reported that endogenous
ligand SLURP1 binds to a7 nAChRs and facilitates apoptosis, while
SLURP2 binds to a3 nAChRs and prevents apoptosis (Arredondo
et al., 2005, 2006, 2007; Moriwaki et al., 2007).
Future studies should be conducted in order to clarify the
subunit composition of nAChRs in RPE cells and to understand
nAChRs function under normal and pathological conditions. We
can conclude that RPE cells express a7 nAChRs as well as at least
one endogenous nicotinic modulator, lynx1. These receptors may be
involved in the pathological progression of ocular degenerative
diseases, such as AMD, and their study could provide new therapeutic
approaches for achieving successful treatments.
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